Proveca Ltd

Proveca Ltd company information, Employees & Contact Information

Explore related pages

Related company profiles:

Proveca Ltd is a specialist UK based pharmaceutical company developing and licensing off-patent medicines to improve the lives of children in Europe, many of whom have chronic conditions requiring long term drug treatment. Proveca was established in 2010 by Dr Helen Shaw, MBChB and Dr Simon Bryson PhD, to bring much needed licensed medicines to children throughout Europe. Currently, 50-90% of the medicines children take are in the wrong format and/or are not licensed for their use. Proveca are leading the way in licensing children's medicines using the European regulatory framework, the Paediatric Use Marketing Authorisation (PUMA) process. The regulation was specifically designed to increase the number of off-patent medicines being developed and licensed for children. Proveca see to provide children with the medicines they need in an appropriate format and with a valid licence throughout Europe. Utilising the experiences and needs of children, their carers and their doctors. Proveca seek to tailor the features and the benefits of its products to the specific requirements of children. For more information please email enquiries@proveca.co.uk

Company Details

Employees
76
Founded
-
Address
Manchester, Greater Manchester, Gb
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Manchester, Greater Manchester
Looking for a particular Proveca Ltd employee's phone or email?

Proveca Ltd Questions

News

Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: An open‐label study extension of the SALIVA trial - Fayoux - 2025 - Developmental Medicine & Child Neurology - Wiley Online Library

Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: An open‐label study extension of the SALIVA trial - Fayoux - 2025 - Developmental Medicine & Child Neurology Wiley Online Library

The tiny tablet that baby heart patients can swallow - dispersing in saliva to help lower blood pressure and bolster blood flow - Daily Mail

The tiny tablet that baby heart patients can swallow - dispersing in saliva to help lower blood pressure and bolster blood flow Daily Mail

Hemodynamic and metabolic effects of a new pediatric dobutamine formulation in hypoxic newborn pigs - Nature

Hemodynamic and metabolic effects of a new pediatric dobutamine formulation in hypoxic newborn pigs Nature

Cerebral Palsy Treatment Market Growth, Opportunities, and Industry Forecast - SkyQuest Technology

Cerebral Palsy Treatment Market Growth, Opportunities, and Industry Forecast SkyQuest Technology

Paediatric pharmaceutical company in £4m funding for drug launch - TheBusinessDesk.com

Paediatric pharmaceutical company in £4m funding for drug launch TheBusinessDesk.com

The world's next great stock market 'disruptors' - and how they can make YOU rich - This is Money

The world's next great stock market 'disruptors' - and how they can make YOU rich This is Money

Top Proveca Ltd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant